Defunct Company
Total Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
345
NCT01434693
Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2011
Completion: Sep 30, 2012
NCT01576471
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Phase: Phase 2
Start: Jul 31, 2012
Completion: Oct 31, 2014
NCT01520558
CNDO-109-AANK for AML in First Complete Remission (CR1)
Phase: Phase 1/2
Start: Dec 31, 2012
Completion: Feb 28, 2018
NCT01836939
Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis
Role: Collaborator
Start: Mar 31, 2013
Completion: Sep 30, 2014
NCT01953354
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
Start: Nov 30, 2013
Completion: Nov 30, 2015
NCT02011269
TSO for Plaque Psoriasis
Start: Mar 31, 2014
Completion: Not specified
NCT02140112
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder
Start: May 31, 2014
Completion: Apr 30, 2015